Study suggests blood test could guide precision treatment in bladder cancer
A blood test that can detect tiny amounts of circulating cancer DNA may be able to identify risk of cancer recurrence and guide precision treatment in bladder cancer following surgery, according to a...
View ArticleNovel approach yields potential drug candidate for bladder cancer
A new approach to molecular drug design has yielded a highly promising bladder cancer drug, which induced rapid shedding of tumour cells and resulted in a significant reduction in tumour size when used...
View ArticleExploiting urine RNAs as diagnostic markers of bladder cancer
Oncotarget published “Transcriptome analyses of urine RNA reveal tumor markers for human bladder cancer: validated amplicons for RT-qPCR-based detection” which reported that in case of bladder cancer,...
View ArticleEAU 2021: Nicotine by-product can predict recurrence of cancer
A by-product of nicotine, found in the urine of smokers, could be used to identify when bladder cancer has returned, new research has found. The pilot study, presented at the 2021 European Association...
View ArticleAdvanced bladder cancers respond to immunotherapy regardless of gene mutation...
A new study has demonstrated that patients with advanced bladder cancers whose tumours have a mutated FGFR3 gene respond to immunotherapy treatment in a manner that is similar to patients without that...
View ArticleMore genetic markers for inherited testicular cancer
A meta-analysis of nearly 200,000 men revealed 22 new genetic locations that could be susceptible to inherited testicular germ cell tumours (TGCT) — a 40 percent increase in the number of regions known...
View ArticleAUA 2021: Researchers find early stage micropapillary bladder cancer outcomes...
A recent study from Fox Chase Cancer Center has found that in patients treated with radical cystectomy – removal of the bladder – those with cT1 micropapillary bladder cancer had similar or worse...
View ArticleESMO 2021: NORSE Study
Highlights on erdafitinib in advanced urothelial cancer with FGFRa alterations: The NORSE study
View ArticleIsrael’s quality indicators show increase in breast and colorectal cancer...
Researchers from Hebrew University-Hadassah in Jerusalem, Israel, and Cardioinfantil Foundation, Cardiology Institute in Bogota, Colombia, conducted a repeated, cross-sectional study to examine whether...
View ArticleBelzutifan induced strong responses in patients with von Hippel-Lindau...
Results from a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center in the USA showed that treatment with belzutifan, a small-molecule inhibitor of hypoxia-inducible...
View Article
More Pages to Explore .....